Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01226 |
| Species: | Homo sapiens |
| Position : | chr3:181428000-181429000 |
| Year: | 2018 |
| Title: | Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 30033119 |
| MONDO: | |
| Tissue: | Inner cell mass |
| Tissue Ontology ID: | UBERON:0000087 |
| Cell Source: | H9 human embryonic stem cells |
| CVCL ID: | CVCL_9774 |
| Cell Type: | embryonic stem cell |
| Cell Ontology ID: | CL:0002322 |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | ChIP-seq, ATAC-seq |
| Low Throughput Method: | qRT-PCR, and ChIP-qPCR |
| Target gene : | SOX2 |
| TF name : | NANOG |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| NANOG | POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | reactome | 13 |
| NANOG | POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | reactome | 10 |
| NANOG | Transcriptional regulation of pluripotent stem cells | reactome | 28 |